TuHURA Biosciences, Inc. (HURA)
NASDAQ: HURA · Real-Time Price · USD
4.880
+0.030 (0.62%)
At close: Feb 4, 2025, 4:00 PM
4.850
-0.030 (-0.61%)
After-hours: Feb 4, 2025, 5:06 PM EST

TuHURA Biosciences Stock Forecast

Stock Price Forecast

The 1 analyst with a 12-month price forecast for TuHURA Biosciences stock has a target of 11, which predicts an increase of 125.41% from the current stock price of 4.88.

Analyst Consensus: Strong Buy
Target Low Average Median High
Price $11 $11 $11 $11
Change +125.41% +125.41% +125.41% +125.41%
* Price targets were last updated on Dec 19, 2024.

Analyst Ratings

According to 1 stock analyst, the rating for TuHURA Biosciences is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating Dec '24Jan '25
Strong Buy 11
Buy 00
Hold 00
Sell 00
Strong Sell 00
Total 11

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
Rodman & Renshaw
Rodman & Renshaw
Strong Buy
Initiates
$11
Strong Buy Initiates $11 +125.41% Dec 19, 2024
More Analyst Ratings

Financial Forecast

Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-0.47
from -0.43
EPS Next Year
-0.43
from -0.47
Fiscal Year FY 2022 FY 2023 FY 2024 FY 2025 FY 2026 FY 2027 FY 2028 FY 2029
Period Ending Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026 Dec 31, 2027 Dec 31, 2028 Dec 31, 2029
Revenue
----10.75M34.52M21.44M36.26M
Revenue Growth
-----221.29%-37.91%69.15%
EPS
--0.43-0.47-0.43-0.300.30--
EPS Growth
--------
Forward PE
-----16.50--
No. Analysts --333333
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 202420252026202720282029
High n/a n/a 22.1M
Avg n/a n/a 10.7M
Low n/a n/a n/a

Revenue Growth

Revenue Growth 202420252026202720282029
High - - -
Avg - - -
Low - - -

EPS Forecast

EPS 2024202520262027
High -0.48 -0.44 -0.30
Avg -0.47 -0.43 -0.30
Low -0.45 -0.41 -0.28

EPS Growth

EPS Growth 2024202520262027
High - - -
Avg - - -
Low - - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.